LGR5 positivity defines stem-like cells in colorectal cancer.

Like normal colorectal epithelium, colorectal carcinomas (CRCs) are organized hierarchically and include populations of cells with stem-like properties. Leucine-rich-repeat-containing G-protein-coupled receptor 5 (LGR5) is associated with these stem cells in normal colorectal epithelium; however, the precise function of LGR5 in CRC remains largely unknown. Here, we analyzed the functional and molecular consequences of short hairpin RNA-mediated silencing of LGR5 in CRC cell lines SW480 and HT-29. Additionally, we exposed Lgr5-EGFP-IRES-CreERT2 mice to azoxymethane/dextrane sodium sulfate (AOM/DSS), which induces inflammation-driven colon tumors. Tumors were then flow-sorted into fractions of epithelial cells that expressed high or low levels of Lgr5 and were molecularly characterized using gene expression profiling and array comparative genomic hybridization. Silencing of LGR5 in SW480 CRC cells resulted in a depletion of spheres but did not affect adherently growing cells. Spheres expressed higher levels of several stem cell-associated genes than adherent cells, including LGR5. Silencing of LGR5 reduced proliferation, migration and colony formation in vitro and tumorigenicity in vivo. In accordance with these results, NOTCH signaling was downregulated upon LGR5 silencing. In AOM/DSS-induced colon tumors, Lgr5 high cells showed higher levels of several stem cell-associated genes and higher Wnt signaling than Lgr5 low tumor cells and Lgr5 high normal colon cells. Array comparative genomic hybridization revealed no genomic imbalances in either tumor cell fraction. Our data elucidate mechanisms that define the role of LGR5 as a marker for stem-like cells in CRC.

[1]  R. Leurs,et al.  The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice. , 2010, The Journal of clinical investigation.

[2]  Irving L Weissman,et al.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.

[3]  O. Sampetrean,et al.  Maintenance of HCT116 colon cancer cell line conforms to a stochastic model but not a cancer stem cell model , 2009, Cancer science.

[4]  D. Aust,et al.  [Barrett's esophagus. An update]. , 2012, Der Pathologe.

[5]  Louis Vermeulen,et al.  Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.

[6]  B. Bao,et al.  Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. , 2011, Cancer letters.

[7]  P. Lichter,et al.  LGR5 is a Marker of Poor Prognosis in Glioblastoma and is Required for Survival of Brain Cancer Stem‐Like Cells , 2013, Brain pathology.

[8]  種瀬 啓士.  G-protein-coupled receptor GPR49 is up-regulated in basal cell carcinoma and promotes cell proliferation and tumor formation , 2009 .

[9]  W. Bodmer,et al.  Cancer stem cells from colorectal cancer-derived cell lines , 2010, Proceedings of the National Academy of Sciences.

[10]  Charles Giardina,et al.  Mouse models for the study of colon carcinogenesis. , 2008, Carcinogenesis.

[11]  Markus F Neurath,et al.  An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression , 2007, Nature Protocols.

[12]  Zang Ai-hua,et al.  Stem Cells,Cancer and Cancer Stem Cells , 2005 .

[13]  Sheng-Cai Lin,et al.  ChIP-seq and functional analysis of the SOX2 gene in colorectal cancers. , 2010, Omics : a journal of integrative biology.

[14]  Yan Zhang,et al.  Notch1 regulates the growth of human colon cancers , 2010, Cancer.

[15]  Shuji Ogino,et al.  Differential WNT activity in colorectal cancer confers limited tumorigenic potential and is regulated by MAPK signaling. , 2012, Cancer research.

[16]  T. Beißbarth,et al.  Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy. , 2011, Carcinogenesis.

[17]  Q. Lin,et al.  R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/β-catenin signaling , 2011, Proceedings of the National Academy of Sciences.

[18]  J. Haveman,et al.  Clonogenic assay of cells in vitro , 2006, Nature Protocols.

[19]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[20]  Alexander van Oudenaarden,et al.  The Lgr 5 intestinal stem cell signature : robust expression of proposed quiescent ‘ þ 4 ’ cell markers , 2012 .

[21]  Jane E. Visvader,et al.  Cells of origin in cancer , 2011, Nature.

[22]  Jun-ling Liu,et al.  Activation of notch‐1 enhances epithelial–mesenchymal transition in gefitinib‐acquired resistant lung cancer cells , 2012, Journal of cellular biochemistry.

[23]  H. Clevers,et al.  Tracking adult stem cells , 2011, EMBO reports.

[24]  L. Ricci-Vitiani,et al.  Therapeutic implications of colon cancer stem cells. , 2010, World journal of gastroenterology.

[25]  Thomas Ried,et al.  Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors , 1996, Genes, chromosomes & cancer.

[26]  Kathleen M. Smith,et al.  Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors , 2006, Cancer biology & therapy.

[27]  Tao Zhang,et al.  Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. , 2009, Cancer research.

[28]  T. Ried,et al.  The consequences of chromosomal aneuploidy on the transcriptome of cancer cells. , 2012, Biochimica et biophysica acta.

[29]  H. Clevers,et al.  Identification of stem cells in small intestine and colon by marker gene Lgr5 , 2007, Nature.

[30]  K. Polyak,et al.  Intra-tumour heterogeneity: a looking glass for cancer? , 2012, Nature Reviews Cancer.

[31]  C. Paraskeva,et al.  LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs. , 2013, Carcinogenesis.

[32]  W. de Lau,et al.  Monoclonal Antibodies Against Lgr5 Identify Human Colorectal Cancer Stem Cells , 2012, Stem cells.

[33]  S. Lipkin,et al.  NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer. , 2010, Cancer research.

[34]  Hans Clevers,et al.  Crypt stem cells as the cells-of-origin of intestinal cancer , 2009, Nature.

[35]  Yidong Chen,et al.  Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome. , 2008, Cancer research.

[36]  T. Ried,et al.  Genome and transcriptome profiles of CD133-positive colorectal cancer cells. , 2011, The American journal of pathology.

[37]  Yingjie Yu,et al.  The Wnt/β-catenin pathway regulates growth and maintenance of colonospheres , 2010, Molecular Cancer.

[38]  R. Simon,et al.  Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas. , 2007, Cancer research.

[39]  Thomas Ried,et al.  Carcinogen-induced colon tumors in mice are chromosomally stable and are characterized by low-level microsatellite instability , 2004, Oncogene.

[40]  Hans Clevers,et al.  Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas , 2012, Science.

[41]  T. Beißbarth,et al.  Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/β-catenin pathway in colorectal cancer. , 2013, Cancer research.

[42]  A. Burgess,et al.  LGR5 Is a Negative Regulator of Tumourigenicity, Antagonizes Wnt Signalling and Regulates Cell Adhesion in Colorectal Cancer Cell Lines , 2011, PloS one.

[43]  Hans Clevers,et al.  Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling , 2011, Nature.

[44]  M. Kelliher,et al.  NOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumorsphere-forming activity in vitro , 2012, Breast Cancer Research.

[45]  Hans Clevers,et al.  The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. , 2011, Cell stem cell.

[46]  Peter Dirks,et al.  Cancer stem cells: an evolving concept , 2012, Nature Reviews Cancer.

[47]  S. Anant,et al.  Honokiol in Combination with Radiation Targets Notch Signaling to Inhibit Colon Cancer Stem Cells , 2012, Molecular Cancer Therapeutics.

[48]  J. Visvader,et al.  Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.

[49]  M. Ghiani,et al.  LGR5 deficiency deregulates Wnt signaling and leads to precocious Paneth cell differentiation in the fetal intestine. , 2009, Developmental biology.